Additionally, the cytotoxic effect of etoposide alone and in combination with trastuzumab or peruzumab was checked in breast cancer cells such as MCF-7 (HER2-) and MDA-MB-231 (HER2-) and HCC1954 (HER2+). This evidence concerns the gene ERBB2 and breast carcinoma.